Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nir Hacohen, Ph.D.

Co-Author

This page shows the publications co-authored by Nir Hacohen and Eric Lander.
Connection Strength

1.321
  1. Prioritizing disease and trait causal variants at the TNFAIP3 locus using functional and genomic features. Nat Commun. 2020 03 06; 11(1):1237.
    View in: PubMed
    Score: 0.225
  2. Positional specificity of different transcription factor classes within enhancers. Proc Natl Acad Sci U S A. 2018 07 24; 115(30):E7222-E7230.
    View in: PubMed
    Score: 0.201
  3. Getting personal with neoantigen-based therapeutic cancer vaccines. Cancer Immunol Res. 2013 Jul; 1(1):11-5.
    View in: PubMed
    Score: 0.139
  4. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009 Mar 12; 458(7235):223-7.
    View in: PubMed
    Score: 0.104
  5. The plasticity of dendritic cell responses to pathogens and their components. Science. 2001 Oct 26; 294(5543):870-5.
    View in: PubMed
    Score: 0.063
  6. Genome-wide enhancer maps link risk variants to disease genes. Nature. 2021 05; 593(7858):238-243.
    View in: PubMed
    Score: 0.061
  7. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial. Nature. 2019 01; 565(7738):234-239.
    View in: PubMed
    Score: 0.052
  8. Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2018 03 14; 555(7696):402.
    View in: PubMed
    Score: 0.049
  9. The Human Cell Atlas. Elife. 2017 12 05; 6.
    View in: PubMed
    Score: 0.048
  10. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017 07 13; 547(7662):217-221.
    View in: PubMed
    Score: 0.047
  11. A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors. Nat Genet. 2017 Feb; 49(2):193-203.
    View in: PubMed
    Score: 0.045
  12. Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia. Cancer Cell. 2014 Dec 08; 26(6):813-825.
    View in: PubMed
    Score: 0.039
  13. Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5' sites. Cell Rep. 2014 Jul 10; 8(1):284-96.
    View in: PubMed
    Score: 0.038
  14. Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia. Blood. 2014 Jul 17; 124(3):453-62.
    View in: PubMed
    Score: 0.038
  15. Somatic mutation as a mechanism of Wnt/ß-catenin pathway activation in CLL. Blood. 2014 Aug 14; 124(7):1089-98.
    View in: PubMed
    Score: 0.037
  16. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell. 2013 Feb 14; 152(4):714-26.
    View in: PubMed
    Score: 0.034
  17. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med. 2011 Dec 29; 365(26):2497-506.
    View in: PubMed
    Score: 0.032
  18. Highly parallel identification of essential genes in cancer cells. Proc Natl Acad Sci U S A. 2008 Dec 23; 105(51):20380-5.
    View in: PubMed
    Score: 0.026
  19. Genome-scale loss-of-function screening with a lentiviral RNAi library. Nat Methods. 2006 Sep; 3(9):715-9.
    View in: PubMed
    Score: 0.022
  20. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell. 2006 Mar 24; 124(6):1283-98.
    View in: PubMed
    Score: 0.021
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.